Seneca Partners

Seneca Partners

Redx hails progress

DRUG development company Redx Pharma has hailed a year of progress as it released its first full year results since its AIM-listing last March. Despite pre-tax losses more than doubling from £4.3m to £8.8m, founder and chief executive Dr Neil…

Seneca behind Smart Storage growth

Smart Storage has announced expansion plans backed by funding of more than £2.5m from Seneca Partners. The Liverpool-based smart storage firm has acquired new sites in Liverpool and Altrincham, and is also launching a new concept at its Widnes site. Haydock-based…

£1.5m placing closed

OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing products to tackle obesity, high cholesterol and diabetes is pleased to announce that it has raised £1,500,000, before expenses through the issue of 2,000,000 new ordinary shares at a price…

Lightning strike for PTSG

Premier Technical Services Group (PTSG), the niche specialist services provider, has bought a designer, installer and maintainer of lightning protection and earthing systems for £1.1m.   “We are very pleased to welcome JW Gray, a long established and respected lightning…

Evgen completes AIM IPO

Shares in Liverpool-based drug development company Evgen Pharma made their debut on AIM today after a successful and over-subscribed placing. The company has raised £6.3m after expenses through the listing. It has placed 18.9m shares at 37p with institutional and other…

Premaitha reveals 100% accuracy

AN independent study into Premaitha Health’s newly-launched IONA non-invasive prenatal test (NIPT) has revealed 100% accuracy. The Manchester-based company’s NIPT test detects the risk of a fetus being by Down’s Syndrome and other serious genetic conditions such at Patau’s Syndrome and…

Seneca Scoops Two Awards

Seneca Partners is pleased to announce success at the Insider Dealmaker Awards 2015. Seneca Partners sister company, Acceleris Capital, won ‘AIM Deal of the Year’ for it’s work on the flotation of Redx Pharma. Acceleris Chief Executive Norman Molyneux is…

Two wins at the Insider North West Dealmakers Awards

Seneca and sister company Acceleris Capital Limited have reason to celebrate this morning following two victories at the Insider North West Dealmaker Awards 2015. Acceleris Capital’s Simon Thorn won the prestigious Young Dealmaker of the Year 2015. Simon was recognised…

Seneca Supports UK’s First Starbucks Franchise

Seneca Partners are pleased to announce they have supported an exciting multi-million pound deal by providing a cornerstone seven figure investment to 23.5 Degrees Limited, Starbucks’ first franchisee globally. The transaction was led by Connection Capital and the total funding…

Kalibrate secures Morrisons deal

Seneca EIS portfolio company, Manchester-headquartered Kalibrate Technologies has secured a software-as-a-service (SaaS) contract with retailer Morrisons. Under the terms of the contract, Kalibrate’s SaaS solution will manage Morrisons’ competitive fuel prices and demand on a real-time basis across its 336 UK…

Seneca add to Investment Team

Experienced Corporate Finance professional John Davies has joined Seneca Partners as an Investment Director in Seneca’s EIS Investment team John has gained over 10 years corporate finance and business recovery experience working in the Transaction Services and the Business Recovery…

Seneca add to Investment Team

Experienced Corporate Finance professional John Davies has joined Seneca Partners as an Investment Director in Seneca’s EIS Investment team John has gained over 10 years corporate finance and business recovery experience working in the Transaction Services and the Business Recovery…

Seneca backs Insurance firm MBO

Seneca Partners backs the Management Buy-out of Macclesfield based leading Insurance specialist The Insurance Surgery is a leading ‘high risk’ insurance specialist for clients who have pre-existing medical conditions, hazardous occupations and for extreme sports. The business has been acquired…

The Rockar Story

Simon Dixon, founder of Rockar, spent 20 years building the UK’s 3rd largest car retail group Dixon Motors PLC. Upon selling the company to RBS in 2004, Simon has over the last 10 years experienced the car buying process from…

Completion of Clinical Studies

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces the successful completion of clinical studies on its capsular food supplement to reduce cholesterol. OptiBiotix announced in December 2014 that it…

ADC opens second R&D Lab

ADC Bio has commissioned a second dedicated R&D lab to meet customer demand for technical services to support ADCs in pre-clinical development. Surging interest in ADC anti-cancer drugs sees over 150 in pre-clinical development and nearly 50 in clinical trials.…

Chancellor visits Redx labs

The Chancellor George Osborne visited Redx’s Alderley Park site in Cheshire today, meeting staff and touring the laboratories within the anti-infectives business. He used the occasion to announce the creation of a new Catapult in Medicines Technologies. Benefitting from £5m…

Optibiotix pens Spanish deal

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces that it has signed an agreement with the Instituto de Química Orgánica General (“IQOG”) of the Spanish National Research Council (Consejo…

PTSG acquires Pendrich

Premier Technical Services, the niche specialist services provider, has acquired Pendrich Height Services Ltd and NATHS Ltd, specialists in working at height on both conventional and unconventional structures and based in Rosewell near Edinburgh. PTSG will pay a maximum cash…

Ground breaking IONA test

Seneca EIS portfolio company Premaitha Health is on the verge of tapping into a multi-billion pound market with its ground breaking non-invasive prenatal screening test for pregnant women. Chief executive of the Manchester-based company, Dr Stephen Little, said there was…

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance. Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such. Please confirm that you understand this warning and wish to proceed.